Genscript Biotech Corporation ( GNNSF) - Stock Earnings
GNNSF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -25.5 million USD | 518.8 million USD |
| 2025Q4 | -508.3 million USD | 441.6 million USD |
| 2026Q2 | -129.0 million USD | 403.2 million USD |
GNNSF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -95.5 million USD | 839.5 million USD |
| 2024 | 3.0 billion USD | 594.5 million USD |
| 2025 | -533.6 million USD | 960.9 million USD |
| 2026 Est. | — | — |
GNNSF
Price: $5.20
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 13.9 billion